February 9, 2015 / 2:48 PM / 3 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Sohu.com, Regulus Therapeutics, MCG Capital

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks opened lower on Monday, on the heels of disappointing economic data out of China and signs of rising tensions surrounding Greek debt negotiations. The Dow Jones industrial average was down 0.34 percent at 17,763.3, the S&P 500 was down 0.20 percent at 2,051.38 and the Nasdaq Composite was down 0.20 percent at 4,735.12.


The drugmaker said a combination of its experimental Hepatitis C drug in combination with Gilead Sciences Inc’s blockbuster Sovaldi eradicated signs of the virus following six weeks of therapy.

** ATOSSA GENETICS INC, $1.59, +33.61 pct

The medical device maker signed a distribution deal with Thermo Fisher Scientific Inc, the world’s largest maker of scientific instruments.

Atossa will market its FullCYTE breast aspirator device in the United States through Thermo Fisher’s Fisher HealthCare channel under the deal. The device is used by doctors and nurses to collect breast fluid for testing.

** RIO ALTO MINING LTD, $2.9, +9.85 pct

** TAHOE RESOURCES INC, $12.86, -8.86 pct

Canadian gold miner’s U.S.-listed shares rise after bigger rival Tahoe Resources said it would to buy the company for C$1.4 bln ($1.12 bln) in a cash and share deal.

The offer of C$4 a share represents premium of 22.1 pct to Rio Alto’s Friday close on the Toronto Stock Exchange.

** NORDIC AMERICAN TANKER LTD, $9.24, -7.69 pct

The tanker company said it expects six vessels to be drydocked in 2015 and also reported a flat fourth-quarter profit of 1 cent per share.

** SOHU.COM INC, $54.33, -2.79 pct

The company forecast a first-quarter loss and revenue below the average estimate. It also reported fourth-quarter revenue above analysts’ expectation as advertisers spent more on its video and real-estate portals.

** REGULUS THERAPEUTICS INC, $14.86, -11.86 pct

The company said two hepatitis C patients given a single dose of its experimental drug relapsed in a study.

** MCG CAPITAL CORP, $3.96, +4.21 pct

The asset management company said it would explore strategic alternatives including a sale of company and appointed Morgan Stanley as its financial adviser.

** GALENA BIOPHARMA INC, $1.73, +3.59 pct

The company said it enrolled the 700th breast cancer patient in a study to test its experimental immunotherapy drug NeuVax. Galena expects to enroll patients until the end of the first quarter.

** MOTOROLA SOLUTIONS INC, $67.9, +5.01 pct

The walkie-talkie and radio systems maker is looking into a possible sale, Bloomberg reported, citing people familiar with the matter.

Potential buyers could include private-equity firms and defense contractors including Raytheon Co, Honeywell International Inc and General Dynamics Corp, Bloomberg reported, citing one of the sources. (bloom.bg/16rCCCp)

** ALCOA INC, $15.93, -3.86 pct

** CENTURY ALUMINUM CO, $23.48, -7.08 pct

Analysts from J.P. Morgan Securities downgrade Alcoa’s stock to “neutral” from “overweight”, and cut their price target to $18.50 from $20, citing deteriorating aluminum fundamentals and softer global demand.

The brokerage also downgraded Century Aluminum’s stock to “underweight” from “neural”, and lowered its price target to $17.50 from $20.

** NATIONAL BANK OF GREECE, $1.11, -8.26 pct

S&P cut Greece’s long-term sovereign credit rating to “B negative” from “B” on Friday, warning that liquidity restraints on Greek banks would limit the time the new government has to clinch a deal with its creditors.

The bank has now erased all the gains from last week and is racing back towards a record low.

** HASBRO INC, $58.2, +4.41 pct

The second-largest U.S. toymaker reported a better-than-expected quarterly profit, helped by demand for its Transformers, Nerf and Marvel toys in the holiday shopping season.

** COMPUGEN LTD, $7.85, +1.16 pct

The Israeli drug developer said new data shows its experimental cancer therapy has the potential to be a promising immuno-oncology antibody.

** FIFTH STREET FINANCE CORP, $7.25, -14.61 pct

A 17 percent rise in expenses pushed the business development company to a fourth-quarter loss from a profit a year earlier


The rig contractor reported a 7 percent drop in quarterly revenue as demand dropped due to weak oil prices, and said it would not pay a special dividend as it had been doing since 2006.

** QUALCOMM INC, $68.7, +3.54 pct

The U.S. chipmaker is likely to pay China a record fine of around $1 billion, ending a 14-month government investigation into anti-competitive practices, after it made significant progress during talks with the regulator last week.

** MCDONALD’S CORP, $93.09, -0.96 pct

The company’s worldwide same-restaurant sales fell a steeper-than-expected 1.8 percent in January, as it fights to win back diners around the world and shake off the after-effects of a supplier scandal in China.

** NOVO NORDISK A/S, $41.9, -1.25 pct

The Danish drugmaker said it would list its IT services unit NNIT separately on the Copenhagen stock exchange, but declined to give details on the timing and size of the initial public offering (IPO). (Compiled by Amrutha Penumudi in Bengaluru; Editing by Simon Jennings)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below